Appendix Table D-1.
Underlying Conditions Garg et al. (2020) | Corresponding Condition DeCaprio et al. (2020) |
---|---|
Hypertension | Hypertension |
Obesity (BMI>=30) | Severe Obesity (BMI>=40) |
Chronic metabolic disease | No exact match (excluded) |
Diabetes mellitus | Diabetes |
Chronic lung disease | |
Asthma | Asthma |
Chronic obstructive pulmonary disease | (COPD) or emphysema, cystic fibrosis, or chronic bronchitis |
Cardiovascular disease (not hypertension) | |
Coronary artery disease | Rheumatic and other heart disease |
Congestive heart failure | Congestive heart failure |
Neurologic disease | Stroke |
Renal disease | Chronic kidney disease |
Immunosuppressive condition | No exact match (excluded) |
Gastrointestinal/Liver disease | Liver disease |
Blood disorder | No exact match (excluded) |
Rheumatologic/Autoimmune disease | |
No exact match (excluded) |
Notes: Pregnancy is excluded because we do not use it in the PSID estimation. Garg et al. (2020) reports that 30% of obsese patients are severely obese and we apply the percentage uniformly across age groups. We treat all reports of chronic lung disease that are not asthma as being included in COPD, emphysema, cystic fibrosis, or chronic bronchitis. We treat all reports of cardiovascular disease (not hypertension) that are not congestive heart disease as coronary artery disease. We have tested using applying the coefficients for neurocognitive conditions instead of stroke as the corresponding condition for neurologic disease and the results are unchanged. We have also tested using sickle cell/HIV/transplant in DeCaprio et al. (2020) as a match for immunosuppresive conditions in Garg et al. (2020). Again the results are very similar.